$TTOO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in T2 Biosystems, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in T2 Biosystems, Inc.. Get notifications about new insider transactions in T2 Biosystems, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
| Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Sell | S | 3.47 | 4,185 | 14,522 | 66,875 | 71.1 K to 66.9 K (-5.89 %) |
| Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Sell | S | 3.47 | 4,185 | 14,522 | 66,875 | 71.1 K to 66.9 K (-5.89 %) |
| Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Sell | S | 3.35 | 2,166 | 7,256 | 71,060 | 73.2 K to 71.1 K (-2.96 %) |
| Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Sell | S | 3.35 | 2,166 | 7,256 | 71,060 | 73.2 K to 71.1 K (-2.96 %) |
| Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Buy | M | 0.00 | 15,000 | 0 | 73,226 | 58.2 K to 73.2 K (+25.76 %) |
| Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Buy | M | 0.00 | 15,000 | 0 | 73,226 | 58.2 K to 73.2 K (+25.76 %) |
| Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Buy | M | 0.00 | 15,000 | 0 | 58,226 | 43.2 K to 58.2 K (+34.70 %) |
| Feb 05 2019 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Buy | M | 0.00 | 15,000 | 0 | 58,226 | 43.2 K to 58.2 K (+34.70 %) |
| Jan 03 2019 | TTOO | T2 Biosystems, Inc ... | Jones Adrian M | Grant | A | 0.00 | 13,289 | 0 | 4,236,453 | 4.2 M to 4.2 M (+0.31 %) | |
| Jan 03 2019 | TTOO | T2 Biosystems, Inc ... | LIEBMAN SEYMOUR | Director | Option Exercise | M | 0.00 | 9,708 | 0 | 9,708 | |
| Jan 03 2019 | TTOO | T2 Biosystems, Inc ... | LIEBMAN SEYMOUR | Director | Option Exercise | A | 0.00 | 13,289 | 0 | 13,289 | |
| Jan 03 2019 | TTOO | T2 Biosystems, Inc ... | LIEBMAN SEYMOUR | Director | Buy | M | 0.00 | 9,708 | 0 | 27,708 | 18 K to 27.7 K (+53.93 %) |
| Jan 03 2019 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Option Exercise | M | 0.00 | 9,708 | 0 | 9,708 | |
| Jan 03 2019 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Option Exercise | A | 0.00 | 13,289 | 0 | 13,289 | |
| Jan 03 2019 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Buy | M | 0.00 | 9,708 | 0 | 77,708 | 68 K to 77.7 K (+14.28 %) |
| Nov 08 2018 | TTOO | T2 Biosystems, Inc ... | Lapidus Stanley | Director | Option Exercise | M | 1.16 | 27,058 | 31,387 | 0 | |
| Nov 08 2018 | TTOO | T2 Biosystems, Inc ... | Lapidus Stanley | Director | Sell | S | 5.29 | 6,048 | 31,994 | 53,010 | 59.1 K to 53 K (-10.24 %) |
| Nov 08 2018 | TTOO | T2 Biosystems, Inc ... | Lapidus Stanley | Director | Buy | M | 1.16 | 27,058 | 31,387 | 59,058 | 32 K to 59.1 K (+84.56 %) |
| Sep 21 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | M | 3.22 | 16,602 | 53,458 | 0 | |
| Sep 21 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | M | 3.22 | 31,603 | 101,762 | 0 | |
| Sep 21 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Sell | S | 6.18 | 48,205 | 297,907 | 43,226 | 91.4 K to 43.2 K (-52.72 %) |
| Sep 21 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Buy | M | 3.22 | 16,602 | 53,458 | 91,431 | 74.8 K to 91.4 K (+22.19 %) |
| Sep 21 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Buy | M | 3.22 | 31,603 | 101,762 | 74,829 | 43.2 K to 74.8 K (+73.11 %) |
| Sep 20 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | M | 3.22 | 27,499 | 88,547 | 31,603 | |
| Sep 20 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | M | 2.25 | 10,403 | 23,407 | 0 | |
| Sep 20 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | M | 2.25 | 1,361 | 3,062 | 10,403 | |
| Sep 20 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | M | 2.45 | 36,235 | 88,776 | 0 | |
| Sep 20 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | M | 1.96 | 29,411 | 57,646 | 0 | |
| Sep 20 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | M | 1.31 | 18,588 | 24,350 | 0 | |
| Sep 20 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | M | 1.16 | 14,647 | 16,991 | 0 | |
| Sep 20 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Sell | S | 6.20 | 37,902 | 234,992 | 43,226 | 81.1 K to 43.2 K (-46.72 %) |
| Sep 20 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Buy | M | 3.22 | 27,499 | 88,547 | 81,128 | 53.6 K to 81.1 K (+51.28 %) |
| Sep 20 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Buy | M | 2.25 | 10,403 | 23,407 | 53,629 | 43.2 K to 53.6 K (+24.07 %) |
| Sep 20 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Sell | S | 6.17 | 85,595 | 528,121 | 43,226 | 128.8 K to 43.2 K (-66.44 %) |
| Sep 20 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Sell | S | 6.14 | 14,647 | 89,933 | 128,821 | 143.5 K to 128.8 K (-10.21 %) |
| Sep 20 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Buy | M | 2.25 | 1,361 | 3,062 | 143,468 | 142.1 K to 143.5 K (+0.96 %) |
| Sep 20 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Buy | M | 2.45 | 36,235 | 88,776 | 142,107 | 105.9 K to 142.1 K (+34.23 %) |
| Sep 20 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Buy | M | 1.96 | 29,411 | 57,646 | 105,872 | 76.5 K to 105.9 K (+38.47 %) |
| Sep 20 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Buy | M | 1.31 | 18,588 | 24,350 | 76,461 | 57.9 K to 76.5 K (+32.12 %) |
| Sep 20 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Buy | M | 1.16 | 14,647 | 16,991 | 57,873 | 43.2 K to 57.9 K (+33.88 %) |
| Sep 13 2018 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | SVP, Operations | Option Exercise | M | 0.00 | 10,000 | 0 | 10,000 | |
| Sep 13 2018 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | SVP, Operations | Payment of Exercise | F | 6.49 | 3,522 | 22,858 | 33,633 | 37.2 K to 33.6 K (-9.48 %) |
| Sep 13 2018 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | SVP, Operations | Buy | M | 0.00 | 10,000 | 0 | 37,155 | 27.2 K to 37.2 K (+36.83 %) |
| Jul 24 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Payment of Exercise | F | 6.72 | 8,721 | 58,605 | 43,226 | 51.9 K to 43.2 K (-16.79 %) |
| Jul 24 2018 | TTOO | T2 Biosystems, Inc ... | McDonough John | President & CEO | Payment of Exercise | F | 6.72 | 35,295 | 237,182 | 358,614 | 393.9 K to 358.6 K (-8.96 %) |
| Jul 24 2018 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | See Remarks | Payment of Exercise | F | 6.72 | 7,824 | 52,577 | 27,155 | 35 K to 27.2 K (-22.37 %) |
| Jul 24 2018 | TTOO | T2 Biosystems, Inc ... | Sprague John M | Chief Financial Off ... | Payment of Exercise | F | 6.72 | 5,619 | 37,760 | 11,673 | 17.3 K to 11.7 K (-32.49 %) |
| Jul 24 2018 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Payment of Exercise | F | 6.72 | 7,824 | 52,577 | 42,967 | 50.8 K to 43 K (-15.40 %) |
| Jun 29 2018 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Buy | M | 0.00 | 24,086 | 0 | 50,791 | 26.7 K to 50.8 K (+90.19 %) |
| Jun 29 2018 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | See Remarks | Buy | M | 0.00 | 24,086 | 0 | 34,979 | 10.9 K to 35 K (+221.11 %) |
| Jun 29 2018 | TTOO | T2 Biosystems, Inc ... | Sprague John M | Chief Financial Off ... | Buy | M | 0.00 | 17,292 | 0 | 17,292 | 0 to 17.3 K |
| Jun 29 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Buy | M | 0.00 | 26,847 | 0 | 51,947 | 25.1 K to 51.9 K (+106.96 %) |
| Jun 29 2018 | TTOO | T2 Biosystems, Inc ... | McDonough John | President and CEO | Buy | M | 0.00 | 108,696 | 0 | 393,909 | 285.2 K to 393.9 K (+38.11 %) |
| Jun 12 2018 | TTOO | T2 Biosystems, Inc ... | Jones Adrian M | Grant | A | 0.00 | 9,000 | 0 | 4,224,894 | 4.2 M to 4.2 M (+0.21 %) | |
| Jun 12 2018 | TTOO | T2 Biosystems, Inc ... | GOLDMAN SACHS GROUP INC | Grant | A | 0.00 | 9,000 | 0 | 4,224,894 | 4.2 M to 4.2 M (+0.21 %) | |
| Jun 12 2018 | TTOO | T2 Biosystems, Inc ... | Cima Michael J. | Director | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Jun 12 2018 | TTOO | T2 Biosystems, Inc ... | LIEBMAN SEYMOUR | Director | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Jun 12 2018 | TTOO | T2 Biosystems, Inc ... | Lapidus Stanley | Director | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Jun 12 2018 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Jun 12 2018 | TTOO | T2 Biosystems, Inc ... | CUMMING JOHN W | Director | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Jun 08 2018 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | SVP, Operations | Payment of Exercise | F | 8.53 | 4,408 | 37,600 | 10,893 | 15.3 K to 10.9 K (-28.81 %) |
| Jun 08 2018 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | SVP, Operations | Grant | A | 0.00 | 13,583 | 0 | 15,301 | 1.7 K to 15.3 K (+790.63 %) |
| Jun 08 2018 | TTOO | T2 Biosystems, Inc ... | McDonough John | President & CEO | Payment of Exercise | F | 8.53 | 10,751 | 91,706 | 285,213 | 296 K to 285.2 K (-3.63 %) |
| Jun 08 2018 | TTOO | T2 Biosystems, Inc ... | McDonough John | President & CEO | Grant | A | 0.00 | 33,130 | 0 | 295,964 | 262.8 K to 296 K (+12.60 %) |
| Jun 08 2018 | TTOO | T2 Biosystems, Inc ... | McDonough John | President & CEO | Sell | S | 4.28 | 6,292 | 26,930 | 262,834 | 269.1 K to 262.8 K (-2.34 %) |
| Jun 08 2018 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Payment of Exercise | F | 8.53 | 4,705 | 40,134 | 26,705 | 31.4 K to 26.7 K (-14.98 %) |
| Jun 08 2018 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Grant | A | 0.00 | 14,499 | 0 | 31,410 | 16.9 K to 31.4 K (+85.74 %) |
| Jun 08 2018 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Sell | S | 4.28 | 2,202 | 9,425 | 16,911 | 19.1 K to 16.9 K (-11.52 %) |
| Jun 08 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Payment of Exercise | F | 8.53 | 5,312 | 45,311 | 25,100 | 30.4 K to 25.1 K (-17.47 %) |
| Jun 08 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Grant | A | 0.00 | 16,370 | 0 | 30,412 | 14 K to 30.4 K (+116.58 %) |
| Jun 08 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Sell | S | 4.28 | 2,202 | 9,425 | 14,042 | 16.2 K to 14 K (-13.56 %) |
| Jun 05 2018 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Option Exercise | M | 0.00 | 18,000 | 0 | 18,000 | |
| Jun 05 2018 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Buy | P | 7.65 | 4,225 | 32,321 | 10,000 | 5.8 K to 10 K (+73.16 %) |
| Jun 05 2018 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Buy | M | 0.00 | 18,000 | 0 | 68,000 | 50 K to 68 K (+36.00 %) |
| Jun 05 2018 | TTOO | T2 Biosystems, Inc ... | CUMMING JOHN W | Director | Option Exercise | M | 0.00 | 18,000 | 0 | 18,000 | |
| Jun 05 2018 | TTOO | T2 Biosystems, Inc ... | CUMMING JOHN W | Director | Buy | M | 0.00 | 18,000 | 0 | 18,000 | 0 to 18 K |
| Jun 05 2018 | TTOO | T2 Biosystems, Inc ... | Cima Michael J. | Director | Option Exercise | M | 0.00 | 18,000 | 0 | 18,000 | |
| Jun 05 2018 | TTOO | T2 Biosystems, Inc ... | Cima Michael J. | Director | Buy | M | 0.00 | 18,000 | 0 | 207,418 | 189.4 K to 207.4 K (+9.50 %) |
| Jun 05 2018 | TTOO | T2 Biosystems, Inc ... | Lapidus Stanley | Director | Option Exercise | M | 0.00 | 18,000 | 0 | 18,000 | |
| Jun 05 2018 | TTOO | T2 Biosystems, Inc ... | Lapidus Stanley | Director | Sell | S | 8.87 | 6,000 | 53,220 | 32,000 | 38 K to 32 K (-15.79 %) |
| Jun 05 2018 | TTOO | T2 Biosystems, Inc ... | Lapidus Stanley | Director | Buy | M | 0.00 | 18,000 | 0 | 38,000 | 20 K to 38 K (+90.00 %) |
| Jun 05 2018 | TTOO | T2 Biosystems, Inc ... | LIEBMAN SEYMOUR | Director | Option Exercise | M | 0.00 | 18,000 | 0 | 18,000 | |
| Jun 05 2018 | TTOO | T2 Biosystems, Inc ... | LIEBMAN SEYMOUR | Director | Buy | M | 0.00 | 18,000 | 0 | 18,000 | 0 to 18 K |
| Mar 19 2018 | TTOO | T2 Biosystems, Inc ... | McDonough John | President & CEO | Option Exercise | A | 0.00 | 434,783 | 0 | 434,783 | |
| Mar 19 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | A | 0.00 | 107,386 | 0 | 107,386 | |
| Mar 19 2018 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Option Exercise | A | 0.00 | 96,344 | 0 | 96,344 | |
| Mar 19 2018 | TTOO | T2 Biosystems, Inc ... | Barclay Alec | SVP, Operations | Option Exercise | A | 0.00 | 96,344 | 0 | 96,344 | |
| Mar 19 2018 | TTOO | T2 Biosystems, Inc ... | Sprague John M | CFO | Option Exercise | A | 0.00 | 69,170 | 0 | 69,170 | |
| Mar 12 2018 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | A | 5.08 | 90,000 | 457,200 | 90,000 | |
| Mar 12 2018 | TTOO | T2 Biosystems, Inc ... | McDonough John | President and CEO | Option Exercise | A | 5.08 | 300,000 | 1,524,000 | 300,000 | |
| Mar 12 2018 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Option Exercise | A | 5.08 | 90,000 | 457,200 | 90,000 | |
| Mar 02 2018 | TTOO | T2 Biosystems, Inc ... | Sprague John M | Chief Financial Off ... | Option Exercise | A | 5.08 | 225,000 | 1,143,000 | 225,000 | |
| Jan 03 2018 | TTOO | T2 Biosystems, Inc ... | LIEBMAN SEYMOUR | Director | Option Exercise | A | 0.00 | 9,708 | 0 | 9,708 | |
| Jan 03 2018 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Option Exercise | A | 0.00 | 9,708 | 0 | 9,708 | |
| Nov 17 2017 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Buy | P | 4.11 | 1,500 | 6,165 | 5,775 | 4.3 K to 5.8 K (+35.09 %) |
| Jun 08 2017 | TTOO | T2 Biosystems, Inc ... | Spadoro Joanne | Chief Operations Of ... | Buy | P | 3.50 | 5,000 | 17,500 | 5,589 | 589 to 5.6 K (+848.90 %) |
| Jun 08 2017 | TTOO | T2 Biosystems, Inc ... | Dhanda Rahul | SVP of Corporate De ... | Option Exercise | M | 0.48 | 3,000 | 1,440 | 0 | |
| Jun 08 2017 | TTOO | T2 Biosystems, Inc ... | Dhanda Rahul | SVP of Corporate De ... | Buy | P | 3.50 | 1,000 | 3,500 | 5,667 | 4.7 K to 5.7 K (+21.43 %) |
| Jun 08 2017 | TTOO | T2 Biosystems, Inc ... | Dhanda Rahul | SVP of Corporate De ... | Buy | M | 0.48 | 3,000 | 1,440 | 4,667 | 1.7 K to 4.7 K (+179.96 %) |
| Jun 08 2017 | TTOO | T2 Biosystems, Inc ... | Lapidus Stanley | Director | Option Exercise | M | 1.16 | 20,000 | 23,200 | 27,058 | |
| Jun 08 2017 | TTOO | T2 Biosystems, Inc ... | Lapidus Stanley | Director | Buy | M | 1.16 | 20,000 | 23,200 | 20,000 | 0 to 20 K |
| Jun 08 2017 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Buy | P | 3.51 | 1,000 | 3,510 | 10,431 | 9.4 K to 10.4 K (+10.60 %) |
| Jun 08 2017 | TTOO | T2 Biosystems, Inc ... | McDonough John | President and CEO | Option Exercise | M | 1.96 | 21,465 | 42,071 | 106,025 | |
| Jun 08 2017 | TTOO | T2 Biosystems, Inc ... | McDonough John | President and CEO | Option Exercise | M | 1.16 | 11,729 | 13,606 | 0 | |
| Jun 08 2017 | TTOO | T2 Biosystems, Inc ... | McDonough John | President and CEO | Option Exercise | M | 1.16 | 16,806 | 19,495 | 0 | |
| Jun 08 2017 | TTOO | T2 Biosystems, Inc ... | McDonough John | President and CEO | Buy | M | 1.96 | 21,465 | 42,071 | 247,353 | 225.9 K to 247.4 K (+9.50 %) |
| Jun 08 2017 | TTOO | T2 Biosystems, Inc ... | McDonough John | President and CEO | Buy | M | 1.16 | 11,729 | 13,606 | 225,888 | 214.2 K to 225.9 K (+5.48 %) |
| Jun 08 2017 | TTOO | T2 Biosystems, Inc ... | McDonough John | President and CEO | Buy | M | 1.16 | 16,806 | 19,495 | 214,159 | 197.4 K to 214.2 K (+8.52 %) |
| Jun 08 2017 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | M | 1.16 | 4,000 | 4,640 | 14,647 | |
| Jun 08 2017 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Buy | M | 1.16 | 4,000 | 4,640 | 10,411 | 6.4 K to 10.4 K (+62.39 %) |
| Jun 08 2017 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Buy | P | 3.50 | 10,000 | 35,000 | 50,000 | 40 K to 50 K (+25.00 %) |
| Jun 08 2017 | TTOO | T2 Biosystems, Inc ... | Cima Michael J. | Director | Option Exercise | M | 1.96 | 5,000 | 9,800 | 53,823 | |
| Jun 08 2017 | TTOO | T2 Biosystems, Inc ... | Cima Michael J. | Director | Buy | M | 1.96 | 5,000 | 9,800 | 189,418 | 184.4 K to 189.4 K (+2.71 %) |
| Jun 08 2017 | TTOO | T2 Biosystems, Inc ... | DEPTULA-HICKS DARLENE M | SVP & Chief Financi ... | Buy | P | 3.58 | 4,000 | 14,320 | 4,000 | 0 to 4 K |
| Jun 06 2017 | TTOO | T2 Biosystems, Inc ... | Jones Adrian M | Grant | A | 0.00 | 18,000 | 0 | 4,175,240 | 4.2 M to 4.2 M (+0.43 %) | |
| Jun 06 2017 | TTOO | T2 Biosystems, Inc ... | GOLDMAN SACHS GROUP INC | Grant | A | 0.00 | 18,000 | 0 | 4,175,240 | 4.2 M to 4.2 M (+0.43 %) | |
| Jun 06 2017 | TTOO | T2 Biosystems, Inc ... | CUMMING JOHN W | Director | Option Exercise | A | 0.00 | 18,000 | 0 | 18,000 | |
| Jun 06 2017 | TTOO | T2 Biosystems, Inc ... | Cima Michael J. | Director | Option Exercise | A | 0.00 | 18,000 | 0 | 18,000 | |
| Jun 06 2017 | TTOO | T2 Biosystems, Inc ... | LIEBMAN SEYMOUR | Director | Option Exercise | A | 0.00 | 18,000 | 0 | 18,000 | |
| Jun 06 2017 | TTOO | T2 Biosystems, Inc ... | Lapidus Stanley | Director | Option Exercise | A | 0.00 | 18,000 | 0 | 18,000 | |
| Jun 06 2017 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Option Exercise | A | 0.00 | 18,000 | 0 | 18,000 | |
| May 08 2017 | TTOO | T2 Biosystems, Inc ... | Cima Michael J. | Director | Buy | P | 0.00 | 1,400 | 0 | 184,418 | 183 K to 184.4 K (+0.76 %) |
| May 02 2017 | TTOO | T2 Biosystems, Inc ... | DEPTULA-HICKS DARLENE M | Chief Financial Off ... | Option Exercise | A | 4.74 | 175,000 | 829,500 | 175,000 | |
| Mar 17 2017 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Buy | P | 5.97 | 10,000 | 59,700 | 40,000 | 30 K to 40 K (+33.33 %) |
| Feb 13 2017 | TTOO | T2 Biosystems, Inc ... | Dhanda Rahul | SVP of Corporate De ... | Option Exercise | A | 5.67 | 35,000 | 198,450 | 35,000 | |
| Feb 13 2017 | TTOO | T2 Biosystems, Inc ... | Dhanda Rahul | SVP of Corporate De ... | Option Exercise | A | 0.00 | 17,500 | 0 | 17,500 | |
| Dec 01 2016 | TTOO | T2 Biosystems, Inc ... | Gibbs Michael Terrence | General Counsel | Option Exercise | A | 0.00 | 13,000 | 0 | 13,000 | |
| Dec 01 2016 | TTOO | T2 Biosystems, Inc ... | Dhanda Rahul | SVP of Corporate De ... | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| Dec 01 2016 | TTOO | T2 Biosystems, Inc ... | McDonough John | President & CEO | Option Exercise | A | 0.00 | 94,845 | 0 | 94,845 | |
| Dec 01 2016 | TTOO | T2 Biosystems, Inc ... | Lowery Thomas J. | Chief Scientific Of ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
| Sep 22 2016 | TTOO | T2 Biosystems, Inc ... | LIEBMAN SEYMOUR | Director | Option Exercise | A | 6.50 | 66,176 | 430,144 | 66,176 | |
| Sep 08 2016 | TTOO | T2 Biosystems, Inc ... | Spadoro Joanne | Chief Operations Of ... | Option Exercise | A | 6.84 | 146,600 | 1,002,744 | 146,600 | |
| Jul 05 2016 | TTOO | T2 Biosystems, Inc ... | Dhanda Rahul | SVP of Corporate De ... | Option Exercise | M | 2.45 | 3,589 | 8,793 | 31,705 | |
| Jul 05 2016 | TTOO | T2 Biosystems, Inc ... | Dhanda Rahul | SVP of Corporate De ... | Sell | S | 8.16 | 3,589 | 29,286 | 0 | 3.6 K to 0 (-100.00 %) |
| Jul 05 2016 | TTOO | T2 Biosystems, Inc ... | Dhanda Rahul | SVP of Corporate De ... | Buy | M | 2.45 | 3,589 | 8,793 | 3,589 | 0 to 3.6 K |
| Jun 27 2016 | TTOO | T2 Biosystems, Inc ... | Lapidus Stanley | Director | Option Exercise | A | 8.56 | 17,647 | 151,058 | 17,647 | |
| Jun 21 2016 | TTOO | T2 Biosystems, Inc ... | Cima Michael J. | Director | Option Exercise | A | 8.56 | 17,647 | 151,058 | 17,647 | |
| Jun 21 2016 | TTOO | T2 Biosystems, Inc ... | Bilenker Joshua H. | Director | Option Exercise | A | 8.56 | 17,647 | 151,058 | 17,647 | |
| Jun 21 2016 | TTOO | T2 Biosystems, Inc ... | CUMMING JOHN W | Director | Option Exercise | A | 8.56 | 17,647 | 151,058 | 17,647 | |
| Jun 21 2016 | TTOO | T2 Biosystems, Inc ... | WILCOX HARRY W | Director | Option Exercise | A | 8.56 | 17,647 | 151,058 | 17,647 | |
| Jun 21 2016 | TTOO | T2 Biosystems, Inc ... | Elsbree David B | Director | Option Exercise | A | 8.56 | 17,647 | 151,058 | 17,647 | |
| May 17 2016 | TTOO | T2 Biosystems, Inc ... | Lynch Shawn | Chief Financial Off ... | Option Exercise | A | 8.88 | 146,600 | 1,301,808 | 146,600 | |
| Mar 18 2016 | TTOO | T2 Biosystems, Inc ... | Dhanda Rahul | SVP of Corporate De ... | Option Exercise | M | 1.31 | 2,941 | 3,853 | 0 | |
| Mar 18 2016 | TTOO | T2 Biosystems, Inc ... | Dhanda Rahul | SVP of Corporate De ... | Option Exercise | M | 1.16 | 4,647 | 5,391 | 0 | |
| Mar 18 2016 | TTOO | T2 Biosystems, Inc ... | Dhanda Rahul | SVP of Corporate De ... | Sell | S | 8.03 | 2,941 | 23,616 | 0 | 2.9 K to 0 (-100.00 %) |
| Mar 18 2016 | TTOO | T2 Biosystems, Inc ... | Dhanda Rahul | SVP of Corporate De ... | Buy | M | 1.31 | 2,941 | 3,853 | 2,941 | 0 to 2.9 K |
| Mar 18 2016 | TTOO | T2 Biosystems, Inc ... | Dhanda Rahul | SVP of Corporate De ... | Sell | S | 8.00 | 4,647 | 37,176 | 0 | 4.6 K to 0 (-100.00 %) |
| Mar 18 2016 | TTOO | T2 Biosystems, Inc ... | Dhanda Rahul | SVP of Corporate De ... | Buy | M | 1.16 | 4,647 | 5,391 | 4,647 | 0 to 4.6 K |
| Mar 17 2016 | TTOO | T2 Biosystems, Inc ... | Dhanda Rahul | SVP of Corporate De ... | Option Exercise | M | 1.96 | 13,770 | 26,989 | 0 |